公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

475 记录

产品持有公司班级有效性
RF CONTROL SET10287410470ROCHE DIAGNÓSTICA BRASIL LTDAII现有
RF-II (Rheumatoid Factors II) - cobas c10287411434ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Rabbit Monoclonal Negative Control Ig10287411753ROCHE DIAGNÓSTICA BRASIL LTDAII现有
S3 FLUID PACK OMNI S10287410158ROCHE DIAGNÓSTICA BRASIL LTDAII现有
SALI (Salicylate) - cobas c10287411428ROCHE DIAGNÓSTICA BRASIL LTDAII现有
SERUM INDEX (SI2)10287410592ROCHE DIAGNÓSTICA BRASIL LTDAII现有
STFR (Tina-quant Soluble Transferrin Receptor)_cobas c10287411520ROCHE DIAGNÓSTICA BRASIL LTDAII现有
STFR CONTROL SET10287410498ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Serum DAT Control Set10287411740ROCHE DIAGNÓSTICA BRASIL LTDAII现有
T-Uptake CalSet10287411190ROCHE DIAGNÓSTICA BRASIL LTDAII现有
THC2 (ONLINE DAT Cannabinoids II)_cobas c10287411488ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TINA - QUANT (a) ALBUMINA GEN 210287410429ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TOBR2 (ONLINE TDM Tobramycin)_cobas c10287411498ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TP2 (Total Protein Gen.2) - cobas c10287411413ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TP2, PROTEÍNA TOTAL GEN 210287410488ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TPCU3, PROTEÍNA TOTAL URINA/LCR GEN.310287410365ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TPUC3(Total Protein Urine/CSF Gen.3) - cobas c10287411433ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRAPtest10287410984ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRIGL (Triglycerides) - cobas c10287411412ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRIGL, Triglicérides10287410536ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRSF2 (Tina-quant Transferrin ver.2) - cobas c10287411430ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TT - Thrombin Time10287411340ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TT Thrombin Time10287411136ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Testosterona Calset II10287410848ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant Antistreptolysin-O II ASLO210287411805ROCHE DIAGNÓSTICA BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家